Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis-Reference-Cited by-同舟云学术

Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis

Author:

Oyman Abdilkerim¹^ORCID,Başak Mustafa²,Özçelik Melike¹,Özyükseler Deniz Tataroğlu²,Işık Selver³,Yıldırım Mahmut Emre²

Affiliation:

1. Department of Medical Oncology Unıversity of Health Sciences İstanbul Ümraniye Training and Research Hospital Istanbul Turkey

2. Dr. Lutfi Kırdar Kartal Education and Research Hospital Istanbul Turkey

3. Erzurum Education and Research Hospital Erzurum Turkey

Publisher

Wiley

Subject

Oncology,General Medicine

Link

Reference22 articles.

1. National Cancer Institute.Surveillance Epidemiology and End Results(Last accessed on 19 Oct 2019). Available from:www.seer.cancer.gov

4. Resistance to novel antiandrogen therapies in metastatic castration‐resistant prostate cancer;Boudadi K;Clin Med Insights Oncol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献